SUSAN JONES: Open Payments
NPI 1265457741 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,431 in 135 payments from 18 companies in 2025. Trend: 2023 $4,997 · 2024 $3,318 · 2025 $3,431
Food & beverage: $3,431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 71 | $1,810 |
| UCB, Inc. | 8 | $294 |
| Janssen Biotech, Inc. | 11 | $231 |
| Lilly USA, LLC | 9 | $169 |
| AstraZeneca Pharmaceuticals LP | 4 | $159 |
| GENZYME CORPORATION | 4 | $135 |
| Mallinckrodt Hospital Products Inc. | 4 | $124 |
| Aurinia Pharma U.S., Inc. | 5 | $112 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Radius Health, Inc. | 3 | $56 |
Products named: RINVOQ, SKYRIZI, Bimzelx, TREMFYA, TALTZ, SAPHNELO, KEVZARA, ACTHAR.
Industry payments across TX — which companies pay providers there.
